Replies to post #134055 on Biotech Values

[DewDiligence]

3M Co. is one I might add to your list as well. Cuno Division is one reason.

3M’s strong healthcare business is underappreciated by investors, IMO. However, it comprises only 15-20% of 3M’s overall sales, so even I would not characterize 3M as a biotech company :- )

[DewDiligence]

3M acquires CodeRyte for undisclosed amount:

http://finance.yahoo.com/news/3m-acquires-coderyte-inc-130000844.html

3M announced today that it has acquired CodeRyte Inc., an industry leader in clinical natural language processing (NLP) technology and computer-assisted coding solutions for healthcare outpatient providers. Terms of the transaction were not disclosed.

Although it’s better known for Post-It! notes and Scotch tape, 3M has a thriving healthcare business that comprises almost 20% of corporate sales.

p.s. 3M has raised its dividend for 54 (!) consecutive years (#msg-71865338). It also has a new CEO (#msg-71865290).